image



Thank you for your interest in submitting an abstract for consideration at the Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics - 2019 course. Submissions were due by July 8, 2019.  Those accepted will be notified the week of July 29th 2019.  Thank you!


 


CALL FOR CONFERENCE POSTER ABSTRACTS

The poster session reception is an integral part of our Individualizing Medicine conference. The review committee is looking for the best and brightest research and innovation in precision oncology and immunotherapy.   Key to this year's poster session will be innovative use of research, and also application of that research into practice.

THE INDIVIDUALIZING MEDICINE CONFERENCE POSTER SESSION: SEPTEMBER 20th 5:45 PM

General Conference Abstract Submission Deadline: July 8, 2019

Accepted abstracts will be notified the week of July 29th, 2019


POSTER ABSTRACT SUBMISSIONS RULES AND GUIDELINE

  • Submissions are encouraged on topics related to precision oncology, including but not limited to; immunotherapy, genomics, precision therapy, pharmacogenomics, bioinformatics, bio marker discovery + others
  • Clinicians, physician researchers, students and others interested in precision oncology are invited to submit an abstract.
  • Submit the abstract below
  • Abstracts must be submitted in English.
  • Abstracts are limited to 350 words.
  • Do not include tables, figures, pictures or graphs for the abstract— include text only.
  • All abstracts must be submitted by July 8, 2019


Abstract acceptance and conference poster information:

  • In order to participate in the conference, authors must register, and cover the costs of hotel and travel.   As a poster presenter, registration for the pre-conference session is waived.  Main conference registration fees apply (if interested in attending). 
  • Posters will not be displayed if an author is not present. 
  • Velcro will be provided to secure posters on the display board.
  • If accepted, posters must fit within a space that is 8 feet wide and 4 feet high. Do not exceed these dimensions. Poster space will be assigned; a space number will be provided to each author.
  • Each author will be contacted with additional details before the conference.

Please email imconference@mayo.edu if you have questions or need more information about the poster session or guidelines.


 

Presenting Author Information
*
*
*
You may indicate up to 3 co-authors. If you have more than 3, please include their information in the Additional Information area provided below.
First Co-Author Information
Second Co-Author Information
If you have more than 3 co-authors, please include their information in the Additional Information area provided below.
Third Co-Author Information
Abstract Submission
*
*
Include any additional information that you would like the Reviewing Committee to consider regarding your Abstract submission.
Terms of Use
*
All abstract submitters must agree and confirm to *ALL* of the following prior to submission. 1) I affirm that I and all others listed as authors contributed substantively to the writing, review, and work described by this abstract, and further affirm that it was not prepared or written by anyone not listed as an author. 2) I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract. 3) I confirm that I am the sole owner and/or have the rights of all the information and content provided. The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. I herewith grant Mayo Clinic a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the abstract content. 4) I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted. 5) Submission of the abstract constitutes my consent to print and/or electronic publication (e.g. meeting website, program, other promotions, etc.) 6) I confirm all requirements and that disclosure information provided is accurate, complete, and will be disclosed to participants in writing (in abstract and on poster) and verbally at the beginning of any presentation made during the meeting.
*